Legal Cannabis Sales are on the Rise

Wednesday, November 8, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, November 8, 2017 /PRNewswire/ --

According to a report

by Hexa Research, the U.S. medical cannabis market was valued at USD 5.44 billion in 2016, and is expected to be valued at USD 19.48 billion by 2024. The legal cannabis market is expected to be driven by numerous medical benefits of cannabis products,
particularly in such fields like oncology, chronic pain and diabetes. Chronic pain was the largest segment owing to the presence of a large number of patients last year. One major obstacle of the legal cannabis market is to raise money. Scott Jordan who works with entrepreneurs in the industry as director of business development for Colorado-based Dynamic Alternative Finance, explained, "We're seeing some lenders that are looking for higher yields and returns, venturing into this space," he said according to the article. "In terms of equity, we also are seeing some of the larger hedge funds and other family offices," getting involved in cannabis finance, Forbes reported. Global Payout, Inc. (OTC: GOHE), Medical Marijuana, Inc. (OTC: MJNA), Lexaria Bioscience Corp. (OTC: LXRP), Abattis Bioceuticals Corp. (OTCQB: ATTBF), MassRoots, Inc. (OTC: MSRT)

"Retail sales in the U.S. from 20 jurisdictions were $6.5 billion, but according to Greenwave Advisors, that number is projected to grow to $30 billion by 2021. In order to meet the demand for customers, the growers and makers of infused products have to scale up their operations. More automation, more square footage and the ability to manage this fast growth are separating the mom and pop shops from corporate cannabis," Forbes reported.

Global Payout, Inc. (OTC: GOHE) on October 26th announced that, "its majority owned subsidiary, MoneyTrac Technology, Inc. ("MTRAC", the "Company") is currently in the process of ramping-up sales and marketing efforts within Los Angeles County for its newly acquired brand, PotSaver. PotSaver will be releasing its premier Los Angeles publication on January 1st 2017 to coincide with the legalization of recreational use of cannabis in the most populous state in the country, California.

In the last year, PotSaver, a revenue producing, community periodical and online advertising platform that provides listings on discounted cannabis-related products for local dispensaries and shops has established a significant presence within the San Diego County cannabis community behind the efforts of its founder, Aaron Adler. In having been acquired by MTRAC in September 2017, PotSaver has been afforded the foundational and financial support needed to engage in a full-fledged sales and marketing campaign to expand the brand's footprint into both the Orange and Los Angeles County markets.

In recent weeks, MTRAC management has been working diligently to form a powerhouse inside and outside sales and marketing team that will work in collaboration to facilitate the successful launch of PotSaver's publication in Los Angeles. Mr. Adler will supervise this team and expand PotSaver's reach by executing subscription agreements with many of the top dispensaries, service and product providers throughout this newly available market, one that is expected to grow exponentially at the turn of the New Year."

Medical Marijuana, Inc. (OTC: MJNA), recently announced that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has introduced Kannaway® Pure Gold, a full-spectrum hemp oil that provides all the benefits of hemp without the presence of THC. Kannaway® Pure Gold is ideal for anyone who is subject to drug tests, including active and retired military, competing athletes, first-responders, or anyone concerned about THC in their daily CBD supplement. Starting with the same high-quality hemp oil used in all Kannaway products, new Kannaway® Pure Gold Liquid has been filtered down to include non-existent levels of THC to create the highest quality possible cannabinoid-dense CBD oil product.

Lexaria Bioscience Corp. (OTCQB: LXRP) has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Recently, the company announced it has acquired 100% ownership interest in its majority owned subsidiary Poviva Tea, LLC. Lexaria's patented DehydraTECH™ technology is focused on improved delivery methodologies of many commonly used Active Pharmaceutical Ingredients ("APIs") substances. As such, it provides an additional layer of effectiveness that is designed to harmonize with the intellectual property of third parties. Both patented and generic API substances can utilize Lexaria's patented technology.

Abattis Bioceuticals Corp. (OTCQB: ATTBF) on October 26th, 2017 announced that, "it has signed a definitive agreement with Emerald Health Therapeutics Inc. ("Emerald" or "Emerald Health") (TSXV:EMH) involving the wholly-owned Abattis laboratory subsidiary, Northern Vine Canada Inc. ("Northern Vine"). "This is an important turning point for Abattis," said Robert Abenante, President and CEO of Abattis and Northern Vine. "The Company has always desired a strategic partner for its laboratory and has now partnered with one of the most experienced LP's in Canada.  As we commence rolling out our business model for extraction, attracting a partner like Emerald is proof that we have an extremely talented team and a potentially disruptive extraction technology."

MassRoots, Inc. (OTCQB: MSRT) is one of the leading technology platforms for the regulated cannabis industry. On October 18, 2017, the company announced the release of its new Dispensary Finder service with 6,000 entries that catalogue all medical, recreational and delivery-based dispensaries in nine states. MassRoots launched its Dispensary Finder service together with Sweet Leaf, a leading medical and recreational dispensary chain with over 20 locations in Colorado, California and Oregon with headquarters in Denver, as Dispensary Finder's first promoted customer. Dispensaries will be able to claim their stores directly on the MassRoots website. After MassRoots verifies the claim, dispensaries will be able to update their information and connect with consumers through the Dispensary Finder portal. Additional features and exposure will be available to dispensaries for a fee.

Please SIGN UP NOW at To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, has been compensated four thousand dollars for financial news dissemination and pr services by a non-affiliate third party for global payout, inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

For further information: +1-877-601-1879



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store